An innovative biotech company
U3 Pharma GmbH is based in Martinsried, a Munich suburb and home of a large life science cluster with a great number of biotech companies engaged in independent leading‐edge research.
The company was established in 2001 by Professor Axel Ullrich, Director of the Molecular Biology Department at the Max Planck Institute of Biochemistry. He is a champion of translational research and pioneer in cancer research and drug discovery. Ullrich received the 2010 Wolf Prize research on human proto‐oncogenes and development of novel cancer therapies. Ever since its founding days the biotech company has grown to become a leader in the field of targeted cancer drug development and produced a pipeline of novel targeted therapeutics based on the ground‐breaking discoveries made by its founder.